BP
LSBPW

BFAM Partners’s LakeShore Biopharma Warrants LSBPW Stock Holding History

BFAM Partners’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$44K Hold
550,000
– – 100% 1
2024
Q2 		$37.5K Hold
550,000
– – 100% 1
2024
Q1 		$28.1K Hold
550,000
– – 0.71% 2
2023
Q4 		$14.9K Hold
550,000
– – 0.07% 4
2023
Q3 		$19.3K Hold
550,000
– – 0.09% 4
2023
Q2 		$25.9K Hold
550,000
– – 0.04% 7
2023
Q1 		$85.6K Buy
+550,000
New +$83.3K 0.09% 7

Other funds holding LSBPW

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
VAM
Valliance Asset Management Central, Hong Kong $122M AUM 362.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
OCM
Ovata Capital Management Hong Kong $715M AUM 19.57% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

BFAM Partners's LSBPW Position: Q3 2024 in Review

BFAM Partners held its LakeShore Biopharma Warrants (LSBPW) position steady in Q3 2024 at 550,000 shares worth $44K. The position accounts for 100% of the portfolio, ranked #1.

BFAM Partners first reported a position in LSBPW in Q1 2023 and has held it in 7 quarters since. The position peaked at $85.6K in Q1 2023. 21 funds tracked by Wall St. Rank hold LSBPW as of Q3 2024.

  • BFAM Partners held 550,000 shares of LakeShore Biopharma Warrants worth $44K as of Q3 2024.
  • BFAM Partners left its LakeShore Biopharma Warrants share count unchanged in Q3 2024.
  • LakeShore Biopharma Warrants made up 100% of BFAM Partners's portfolio in Q3 2024, its #1 holding.
  • BFAM Partners first reported a position in LakeShore Biopharma Warrants in Q1 2023 and has held it in 7 quarters since.
  • BFAM Partners's LakeShore Biopharma Warrants position peaked at $85.6K in Q1 2023.
  • 21 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2024.

Based on BFAM Partners's 13F filing for Q3 2024, filed 13 Nov 2024.